\documentclass[10pt,a4paper]{article} % Packages \usepackage{fancyhdr} % For header and footer \usepackage{multicol} % Allows multicols in tables \usepackage{tabularx} % Intelligent column widths \usepackage{tabulary} % Used in header and footer \usepackage{hhline} % Border under tables \usepackage{graphicx} % For images \usepackage{xcolor} % For hex colours %\usepackage[utf8x]{inputenc} % For unicode character support \usepackage[T1]{fontenc} % Without this we get weird character replacements \usepackage{colortbl} % For coloured tables \usepackage{setspace} % For line height \usepackage{lastpage} % Needed for total page number \usepackage{seqsplit} % Splits long words. %\usepackage{opensans} % Can't make this work so far. Shame. Would be lovely. \usepackage[normalem]{ulem} % For underlining links % Most of the following are not required for the majority % of cheat sheets but are needed for some symbol support. \usepackage{amsmath} % Symbols \usepackage{MnSymbol} % Symbols \usepackage{wasysym} % Symbols %\usepackage[english,german,french,spanish,italian]{babel} % Languages % Document Info \author{ksellybelly} \pdfinfo{ /Title (cardio-i-shock-chf-htn-acs.pdf) /Creator (Cheatography) /Author (ksellybelly) /Subject (Cardio I: Shock, CHF, HTN, ACS Cheat Sheet) } % Lengths and widths \addtolength{\textwidth}{6cm} \addtolength{\textheight}{-1cm} \addtolength{\hoffset}{-3cm} \addtolength{\voffset}{-2cm} \setlength{\tabcolsep}{0.2cm} % Space between columns \setlength{\headsep}{-12pt} % Reduce space between header and content \setlength{\headheight}{85pt} % If less, LaTeX automatically increases it \renewcommand{\footrulewidth}{0pt} % Remove footer line \renewcommand{\headrulewidth}{0pt} % Remove header line \renewcommand{\seqinsert}{\ifmmode\allowbreak\else\-\fi} % Hyphens in seqsplit % This two commands together give roughly % the right line height in the tables \renewcommand{\arraystretch}{1.3} \onehalfspacing % Commands \newcommand{\SetRowColor}[1]{\noalign{\gdef\RowColorName{#1}}\rowcolor{\RowColorName}} % Shortcut for row colour \newcommand{\mymulticolumn}[3]{\multicolumn{#1}{>{\columncolor{\RowColorName}}#2}{#3}} % For coloured multi-cols \newcolumntype{x}[1]{>{\raggedright}p{#1}} % New column types for ragged-right paragraph columns \newcommand{\tn}{\tabularnewline} % Required as custom column type in use % Font and Colours \definecolor{HeadBackground}{HTML}{333333} \definecolor{FootBackground}{HTML}{666666} \definecolor{TextColor}{HTML}{333333} \definecolor{DarkBackground}{HTML}{663228} \definecolor{LightBackground}{HTML}{FAF8F8} \renewcommand{\familydefault}{\sfdefault} \color{TextColor} % Header and Footer \pagestyle{fancy} \fancyhead{} % Set header to blank \fancyfoot{} % Set footer to blank \fancyhead[L]{ \noindent \begin{multicols}{3} \begin{tabulary}{5.8cm}{C} \SetRowColor{DarkBackground} \vspace{-7pt} {\parbox{\dimexpr\textwidth-2\fboxsep\relax}{\noindent \hspace*{-6pt}\includegraphics[width=5.8cm]{/web/www.cheatography.com/public/images/cheatography_logo.pdf}} } \end{tabulary} \columnbreak \begin{tabulary}{11cm}{L} \vspace{-2pt}\large{\bf{\textcolor{DarkBackground}{\textrm{Cardio I: Shock, CHF, HTN, ACS Cheat Sheet}}}} \\ \normalsize{by \textcolor{DarkBackground}{ksellybelly} via \textcolor{DarkBackground}{\uline{cheatography.com/19318/cs/2380/}}} \end{tabulary} \end{multicols}} \fancyfoot[L]{ \footnotesize \noindent \begin{multicols}{3} \begin{tabulary}{5.8cm}{LL} \SetRowColor{FootBackground} \mymulticolumn{2}{p{5.377cm}}{\bf\textcolor{white}{Cheatographer}} \\ \vspace{-2pt}ksellybelly \\ \uline{cheatography.com/ksellybelly} \\ \end{tabulary} \vfill \columnbreak \begin{tabulary}{5.8cm}{L} \SetRowColor{FootBackground} \mymulticolumn{1}{p{5.377cm}}{\bf\textcolor{white}{Cheat Sheet}} \\ \vspace{-2pt}Published 23rd July, 2014.\\ Updated 11th May, 2016.\\ Page {\thepage} of \pageref{LastPage}. \end{tabulary} \vfill \columnbreak \begin{tabulary}{5.8cm}{L} \SetRowColor{FootBackground} \mymulticolumn{1}{p{5.377cm}}{\bf\textcolor{white}{Sponsor}} \\ \SetRowColor{white} \vspace{-5pt} %\includegraphics[width=48px,height=48px]{dave.jpeg} Measure your website readability!\\ www.readability-score.com \end{tabulary} \end{multicols}} \begin{document} \raggedright \raggedcolumns % Set font size to small. Switch to any value % from this page to resize cheat sheet text: % www.emerson.emory.edu/services/latex/latex_169.html \footnotesize % Small font. \begin{multicols*}{3} \begin{tabularx}{5.377cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{Shock}} \tn % Row 0 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Definition}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Severe cardiovascular failure caused by poor blood flow or inadequate distribution of flow} \tn % Row Count 3 (+ 3) % Row 1 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{1) Hypovolemic Shock}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Hemorrhage, fluid loss, loss of plasma or electrolytes. All result in decreased intravascular volume. Caused by obvious loss or subtle third-space sequestration.} \tn % Row Count 8 (+ 5) % Row 2 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{2) Cardiogenic Shock}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}MI, dysrhythmias, heart failure, valve/septal failure, HTN, myocarditis, cardiac contusion, septum rupture, myocardiopathies} \tn % Row Count 12 (+ 4) % Row 3 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{3) Obstructive Shock}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Tension PTX, pericardial tamponade, obstructive valvular disorder, pulmonary embolism} \tn % Row Count 15 (+ 3) % Row 4 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{4) Distributive Shock (poorly regulated distribution of blood volume)}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Septic shock, SIRS (signs of systemic inflammation w/out end-organ damage), anaphylaxis, neurogenic shock} \tn % Row Count 20 (+ 5) % Row 5 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{Clinical features}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Hypotension + Tachycardia (also AMS, orthostatic changes, metabolic acidosis, insulin resistance, oliguria/anuria, peripheral hypoperfusion)} \tn % Row Count 24 (+ 4) % Row 6 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Sign of end-organ hypoperfusion}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Cool or mottle extremities, and weak ("thready") or absent peripheral pulses} \tn % Row Count 27 (+ 3) % Row 7 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{Treatment}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}1) ABCs. 2) Treat the underlying cause. 3) T-Burg maximizes brain perfusion 4) O2 + IV fluids 5) Urine output at least 0.5 mL/kg/hr 6) Cardiac monitoring and central venous pressure 7) Pressors (Dopamine, etc.) will increase GFR, contractility, HR} \tn % Row Count 34 (+ 7) \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{ACS (Acute Coronary Syndromes)}} \tn % Row 0 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Definition}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Spectrum of problems ranging from unstable angina to MI} \tn % Row Count 3 (+ 3) % Row 1 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{Classified into 2 types}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}ST-elevated and Non-ST-elevated events} \tn % Row Count 5 (+ 2) % Row 2 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Most common etiology of MI}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Preexisting atherosclerotic plaque-{}-\textgreater{}thrombus formation-{}-\textgreater{}prolonged myocardial ischemia-{}-\textgreater{}MI} \tn % Row Count 8 (+ 3) % Row 3 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{What is a common cause of death in MI patients before they can get to hospital?}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}V-fib} \tn % Row Count 11 (+ 3) % Row 4 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Clinical features}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}**Chest pain (most common), sweating, anxiety, weakness, dyspnea, light-headedness, syncope, N/V, fever} \tn % Row Count 15 (+ 4) % Row 5 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{EKG changes}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Acute MI: progression from peaked T-waves-{}-\textgreater{}ST-degment elevation/depression-{}-\textgreater{}Q-wave-{}-\textgreater{}T-wave inversions (hours-days)} \tn % Row Count 19 (+ 4) % Row 6 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{**One of the most sensitive tests to quantify extent of infarction} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}MRI w/ gadolinium} \tn % Row Count 22 (+ 3) % Row 7 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{Treatment-{}-all patients}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}IV fluids + O2 + NO + pain management +/- benzo + anti platelet/anticoagulation + B-blockers +/- CCBs} \tn % Row Count 26 (+ 4) % Row 8 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Treatment-{}-ACS + STEMI}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Reperfusion interention: aspirin + clopidogrel, coronary angiography w/in 90 min, thrombolytic therapy, statin therapy} \tn % Row Count 30 (+ 4) \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{Orthostasis/Postural Hypotension}} \tn % Row 0 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Definition}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}\textgreater{}20mmHg drop in systolic pressure between supine and sitting \&/or standing measurements} \tn % Row Count 3 (+ 3) % Row 1 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{Etiology}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}May be related to reduced cardiac output, paroxysmal cardiac dysrhythmias, low blood volume, medications, and various metabolic and endocrine disorders} \tn % Row Count 8 (+ 5) % Row 2 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{A reversible cause of syncope and major cause of falls in this population}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Elderly} \tn % Row Count 11 (+ 3) % Row 3 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{If the cause is depleted blood volume}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}then there will also be a rise in pulse of more than 15 bpm when testing orthostatics} \tn % Row Count 14 (+ 3) % Row 4 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{If there is no change in pulse accompanying the change in BP}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}then consider CNS disease or peripheral neuropathies} \tn % Row Count 18 (+ 4) % Row 5 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{Labs and Treatment}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Directed at the specific cause} \tn % Row Count 20 (+ 2) \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{Ischemic Heart Disease}} \tn % Row 0 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Definition}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Characterized by insufficient oxygen supply to cardiac muscle} \tn % Row Count 3 (+ 3) % Row 1 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{Etiology}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}1) **Atherosclerotic narrowing (most common). 2) Constriction of coronary arteries. 3) (Rare) congenital, emboli, arteritis, dissection} \tn % Row Count 7 (+ 4) % Row 2 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Risk Factors}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Metabolic syndrome, male, older age, smoking, FmHx, HTN, DM, low-estrogen state, abdominal obesity, inactivity, dyslipidemia, EtOH, low fruits/veggies (cocaine-{}-\textgreater{}MI)} \tn % Row Count 12 (+ 5) % Row 3 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{Metabolic Syndrome is 3 or more of:}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}abdominal obesity, Tri\textgreater{}150, HDL\textless{}40men\textless{}50women, fasting sugar\textgreater{}110, HTN} \tn % Row Count 15 (+ 3) % Row 4 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Clinical Features}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Angina pectoris (chest squeezing/pressure, can radiate, \textless{}3min.), three types:} \tn % Row Count 18 (+ 3) % Row 5 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{1) Stable Angina}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Exacerbated by physical activity, relieved by rest} \tn % Row Count 21 (+ 3) % Row 6 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{2) Prinzmetal's (Variant) Angina}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Caused by vasospasm at rest, exercise capacity preserved} \tn % Row Count 24 (+ 3) % Row 7 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{3) Unstable Angina}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Increasing pattern of pain in previously stable patients. Occurs at rest or with exertion.} \tn % Row Count 27 (+ 3) % Row 8 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Levine's Sign}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Clenched fist over sternums and clenched teeth} \tn % Row Count 29 (+ 2) % Row 9 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{How to relieve angina}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Sublingual nitroglycerin} \tn % Row Count 31 (+ 2) \end{tabularx} \par\addvspace{1.3em} \vfill \columnbreak \begin{tabularx}{5.377cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{Ischemic Heart Disease (cont)}} \tn % Row 10 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{EKG Findings}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Horizontal or downsloping ST-segment depression} \tn % Row Count 2 (+ 2) % Row 11 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{Treatment}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Lifestyle changes, NO, nitrates, B-blockers, CCB, Ranolazine, ASA/Clopidigrel, revascularization} \tn % Row Count 6 (+ 4) \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{CHF}} \tn % Row 0 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Definition}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Clinical syndrome: dyspnea + water/sodium retention} \tn % Row Count 3 (+ 3) % Row 1 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{Results from changes in 1+ of the following}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Contractile ability of heart muscle, preload and after load of the ventricle, and heart rate} \tn % Row Count 6 (+ 3) % Row 2 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Etiologies of these changes}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}MI, pericardial disorders, valvular disorders, congenital abnormalities, and non cardiac causes (high-output heart failure from thyrotoxicosis or severe anemia)} \tn % Row Count 11 (+ 5) % Row 3 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{CHF adversely affects}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Left atrial pressure + cardiac output} \tn % Row Count 13 (+ 2) % Row 4 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Clinical features of LEFT-sided failure}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Exertional dyspnea, non-productive cough, fatigue, orthopnea, PND, basilar rales, gallops, exercise intolerance} \tn % Row Count 17 (+ 4) % Row 5 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{Clinical features of RIGHT-sided failure}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Distended neck veins, hepatic congestion, nausea, dependent pitting edema, *edema + hepatomegaly, (R-sided failure often caused by L-sided failure)} \tn % Row Count 22 (+ 5) % Row 6 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Other symptoms of CHF}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Nocturia, cold/clammy skin, hypotension, narrow pulse pressure, S3 gallop} \tn % Row Count 25 (+ 3) % Row 7 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{CXR signs}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Kerley B lines (aka interstitial edema)} \tn % Row Count 27 (+ 2) % Row 8 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Treatment}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}1) Thiazide or Loop diuretic + ACEi. 2) CCB (amlodipine). 3) Anticoagulants or antiarrhythmics 4) Pacers/difibrillators 5) Coronary \seqsplit{revascularization/transplant}} \tn % Row Count 32 (+ 5) \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{x{2.58804 cm} x{2.38896 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{EKG Locations}} \tn % Row 0 \SetRowColor{LightBackground} Inferior & II, III, aVF \tn % Row Count 1 (+ 1) % Row 1 \SetRowColor{white} Posterior & V1, V2 \tn % Row Count 2 (+ 1) % Row 2 \SetRowColor{LightBackground} Anteroseptal & V1, V2 \tn % Row Count 3 (+ 1) % Row 3 \SetRowColor{white} Anterior & V1, V2, V3 \tn % Row Count 4 (+ 1) % Row 4 \SetRowColor{LightBackground} Anterolateral & V4, V5, V6 \tn % Row Count 5 (+ 1) \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{Hypertension}} \tn % Row 0 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Primary HTN}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Causes 95\% of cases of HTN; multifactorial pathogenesis (genetics, salt, obesity, RAAS, NSAIDs, smoking, lack of exercise, metabolic syndrome)} \tn % Row Count 5 (+ 5) % Row 1 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{Secondary HTN}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}coarc. of aorta, RAS, chronic steroids, Cushings syndrome, pregnancy, thyroid and parathyroid disease, primary hyperaldosteronism, parenchymal renal dz)} \tn % Row Count 10 (+ 5) % Row 2 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Essential HTN is exacerbated in this population}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Males, blacks, sedentary people, smokers} \tn % Row Count 13 (+ 3) % Row 3 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{Hypertensive urgency def.}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Must bring down BP within hours} \tn % Row Count 15 (+ 2) % Row 4 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Hypertensive emergency def.}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Must bring down BP within 1 hour to prevent end-organ damage/death} \tn % Row Count 18 (+ 3) % Row 5 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{Malignant hypertension def.}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Elevated BP + papilledema + \seqsplit{encephalopathy/nephropathy}. In untreated-{}-\textgreater{}progressive renal failure.} \tn % Row Count 22 (+ 4) % Row 6 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Complications of untreated HTN}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Cardiovascular dz, cerebrovascular dz, dementia, renal dz, aortic dissection, and atherosclerotic complications} \tn % Row Count 26 (+ 4) % Row 7 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{Diagnostic criteria-{}-essential HTN}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Systolic \textgreater{}140 OR Diastolic \textgreater{}90 on 3 diff. occasions} \tn % Row Count 29 (+ 3) % Row 8 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Diagnostic criteria-{}-hypertensive urgency}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Systolic \textgreater{}220 OR Diastolic \textgreater{}125} \tn % Row Count 31 (+ 2) \end{tabularx} \par\addvspace{1.3em} \vfill \columnbreak \begin{tabularx}{5.377cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{Hypertension (cont)}} \tn % Row 9 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{Diagnostic criteria-{}-hypertensive emergency}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Diastolic \textgreater{}130 + papilledema} \tn % Row Count 2 (+ 2) % Row 10 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Complications of hypertensive emergency}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Hypertensive encephalopathy, nephropathy, intracranial bleeding, aortic dissection, preeclampsia/eclampsia, pulmonary edema, unstable angina, MI} \tn % Row Count 7 (+ 5) % Row 11 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{{\bf{Treatment-{}-HTN}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}1) DASH diet/lifestyles changes/smoking cessation. 2) Diuretics (*HCTZ). 3) Beta blockers 4) ACEi 5) ARB 6) CCB} \tn % Row Count 11 (+ 4) % Row 12 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{{\bf{Treatment-{}-HTN urgency/emergency}}} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Parenteral agents, but don't lower BP too fast. Use NO, B-blockers, hydrazine, loops, clonidine, nifedipine} \tn % Row Count 15 (+ 4) \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} % That's all folks \end{multicols*} \end{document}